- category:Business
Business
Opthea appoints new CFO, other senior leadership positions
Latest appointees include CMO and VP as the company prepares for 2025 topline phase 3 data readouts on sozinibercept for wet AMD.
Business
Vista Ophthalmics and MST to launch global partnership
Collaboration marks the U.S. commercialization of the Vista 1-Step vitrector and Vista IS anterior chamber maintainer, debuting at AAO next month.
Business
Global Myopia Awareness Coalition adds international members
The Singapore Optometric Association and Optometry Australia have joined the industry coalition’s fight against myopia.
Business
Nicox and Glaukos sign global licensing option for glaucoma and retinal candidate
Agreement includes preclinical research for NCX 1728, the lead compound of a new class of nitric-oxide-donating molecule class.
Business
ANI Pharmaceuticals officially acquires Alimera Sciences
Purchase includes YUTIQ and ILUVIEN, expanding the company’s ophthalmic presence in the rare disease space.
Business
AbbVie and Ripple Therapeutics to develop glaucoma intracameral implant
Collaboration features Ripple’s RTC-620, a sustained-release drug implant with repeat dosing for lowering IOP in OAG and OHT patients.
Business
Sonoma Pharmaceuticals and EMC Pharma to co-market expanded eye care product line
Ongoing agreement now involves HOCl-based Ocucyn and Acuicyn eyelid and eyelash cleansers, with the debut targeted for AAO next month.
Business
Opthea names senior leaders ahead of phase 3 wet AMD data readout
Company anticipates releasing interim data from COAST and ShORe studies in early and mid-2025, respectively.
Business
Samsara Vision promotes industry veteran to COO
Former VP Jason Herod will oversee ongoing U.S.-based trials on the SING IMT intraocular telescope for late-stage AMD.
Business
Newly-launched Tern Therapeutics acquires ex-REGENXBIO gene therapies
Biotech company receives $15 million in funding to advance clinical development of TTX-381 and TTX-181 for treating ocular and CNS manifestations of CNL2 disease.
Business
Advancing Eyecare purchases Eyefficient ophthalmic supplier
North American ophthalmic equipment companies join forces to serve ECPs, third-party distributors, and independent sales reps.
Business
Ocuvex Therapeutics to merge with Visiox Pharmaceuticals
Deal includes Visiox’s OMLONTI, indicated to treat glaucoma and ocular hypertension.
Business
ASOA names ASCRS leader as new executive director
Current ASCRS Foundation Executive Director Abigail Markward is taking the helm.
Business
Bausch + Lomb acquires Trukera Medical
Purchase of the former TearLab Corporation includes the ScoutPro Osmolarity System, a point-of-care portable device for osmolarity testing.
Business
Opthea selects global retinal leaders for Medical Advisory Board
Newly-formed board is led by Chief Medical Advisor Arshad M. Khanani, MD, MA, FASRS.
Business
Sydnexis names long-time industry executive as new leader
Effective Aug. 5, Perry J. Sternberg will take over as CEO of the pediatric myopia-focused pharmaceutical company.
Business
EssilorLuxottica is purchasing a majority stake in Heidelberg Engineering
Multinational eyewear corporation will acquire an 80% stake in the high-tech solutions company.
Business
Merck officially enters ophthalmic space with EyeBio acquisition
Pharmaceutical giant now owns Restoret (EYE103), an investigational, tri-specific antibody for DME and wet AMD.
Business
iOR Partners names leading cataract refractive surgeon as Strategic Advisory Board chairman
Lance J. Kugler, MD, brings extensive office-based surgery experience to the specialty company.
Business